New Hampshire
How Bruesewitz v. Wyeth LLC applies in New Hampshire: state-specific rules, key cases, and bar exam notes for Products Liability (Preemption).
New Hampshire adheres to the principles established in Bruesewitz v. Wyeth LLC concerning preemption of state law by federal vaccine regulations. The state's courts generally recognize that federal law may preempt state products liability claims that challenge the safety or efficacy of vaccines approved by the FDA.
In New Hampshire, federal law under the National Childhood Vaccine Injury Act (NCVIA) preempts state law tort claims against vaccine manufacturers for design defects, as established in Bruesewitz.
The court ruled that state tort claims relating to vaccine side effects are preempted by the federal vaccine program, aligning with Bruesewitz principles.
Confirmed that strict liability claims in the context of vaccines are subject to preemption under federal law.
Provided further clarification on the limitations of state claims involving vaccines and affirmed the federal preemption doctrine.
New Hampshire's approach is consistent with the federal standard established in Bruesewitz, which emphasizes the limitations of state tort claims against vaccine manufacturers. Like the federal framework, New Hampshire courts afford substantial deference to federal law in the context of vaccine safety and efficacy.
Candidates should be aware of the preemption principles articulated in Bruesewitz, as questions may arise in the context of products liability and federal versus state law interactions.